Company Overview
- Website
- apeloa.com
- Phone
- +86 5715-680-9788
- Employees
- 171
- Founded in
- 1989
- Industry
- Materials/Manufacturing
- NAICS Codes
-
32 - Manufacturing325 - Chemical Manufacturing3254 - Pharmaceutical and Medicine Manufacturing32541 - Pharmaceutical and Medicine Manufacturing
- SIC Codes
-
28 - Chemicals and Allied Products283 - Drugs
Financials & Stats
Revenue
$1,400B
Recent News & Media
Ethyl (R)-2-Hydroxy-4-phenylbutyrate (CAS 90315-82-5) Market to Grow Through 2032, Driven by Expanding Use in Pharmaceutical Intermediates and Fine Chemicals
- Jun 24, 2025
- taiwannews.com.tw
GLP-1R Agonists: Pioneering in Metabolic, Neurologic, and Cardiologic Markets - ResearchAndMarkets.com
- May 26, 2025
- businesswire.com
GLP-1R Agonists Label Extensions/Drug Repurposing Market
- May 21, 2025
- globenewswire.com
Novel NLRP3 inhibitor shows neuroprotective effect
- Jan 8, 2025
- bioworld.com
Design, synthesis, and pharmacological characterization of sulfonylurea-based NLRP3 inhibitors: Towards an effective therapeutic strategy for Alzheimer's disease
- Dec 15, 2024
- sciencedirect.com
Synthesis, Structure, and Properties of a Nitrogen–Boron–Nitrogen-Embedded Polycyclic π-System Containing a Pleiaheptalene Framework | Organic Letters
- Nov 28, 2023
- pubs.acs.org
Who is Apeloa Pharmaceutical Co Ltd
Apeloa Pharmaceutical Co Ltd is a pharmaceutical company headquartered in Waltham, Massachusetts. The company employs 171 people and generates $1,400 million in annual revenue. Apeloa offers a range of services and products, including contract research and development manufacturing (CRDMO), generic active pharmaceutical ingredients (APIs), and drug products. They serve clients globally, providing comprehensive support from discovery to commercialization. Apeloa leverages technology to enhance its services, specializing in flow chemistry, fermentation, crystallization, and high potency API capabilities. Their aim is to advance small molecule projects effectively and efficiently. Visit apeloa.com for more information.